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ABSTRACT
Physical inactivity increases the risk to develop type 2 diabetes, a disease characterized by a state of 
insulin resistance. By promoting inflammatory state, ceramides are especially recognized to alter 
insulin sensitivity in skeletal muscle. The present study was designed to analyze, in mice, whether 
muscle ceramides contribute to physical inactivity-induced insulin resistance. For this purpose, we 
used the wheel lock model to induce a sudden reduction of physical activity, in combination with 
myriocin treatment, an inhibitor of de novo ceramide synthesis. Mice were assigned to 3 experimental 
groups: voluntary wheel access group (Active), a wheel lock group (Inactive) and wheel lock group 
treated with myriocin (Inactive-Myr). We observed that 10 days of physical inactivity induces 
hyperinsulinemia and increases HOMA-IR. The muscle ceramide content was not modified by 
physical inactivity and myriocin. Thus, muscle ceramides do not play a role in physical inactivity-
induced insulin resistance. In skeletal muscle, insulin-stimulated Akt phosphorylation and 
inflammatory pathway were not affected by physical inactivity whereas a reduction of GLUT4 content 
was observed. Based on these results, physical inactivity-induced insulin resistance seems related to a 
reduction in GLUT4 content rather than defects in insulin signaling. We observed in inactive mice that 
myriocin treatment improves glucose tolerance, insulin-stimulated Akt, AMPK activation and GLUT4 
content in skeletal muscle. Such effects occur regardless of changes in muscle ceramide content. These 
findings open promising research perspectives to identify new mechanisms of action for myriocin on 
insulin sensitivity and glucose metabolism. 
Key Words: NF-ΚB, HOMA-IR, AMP kinase, Akt, triglycerides
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INTRODUCTION
Physical inactivity is now recognized as a global pandemic promoting the development of numerous 
chronic diseases including coronary heart diseases, type 2 diabetes, cancer or dementia (Booth et al., 
2017; Pedersen 2009). Each year, non-communicable chronic diseases kill 36 million people 
worldwide, including 17.3 million of deaths due to cardiovascular diseases and 1.3 million due to 
diabetes (Lee et al., 2012). Nine million of these deaths occur before 60 years old, while over 5.3 
million deaths could be averted every year if all inactive people performed only 15 to 30 min/day of 
moderate physical exercise (Lee et al., 2012). In addition to morbidity and premature mortality, the 
economic burden of physical inactivity for national governments is estimated worldwide to 53.8 
billion US dollars for health-care systems, and 13.7 billion US dollars for productivity losses (Ding et 
al., 2016). 
For the World Health Organization, a person is considered as physically inactive if he doesn’t meet 
any of these 3 criteria: 30 min of moderate-intensity physical activity on at least 5 days every week, 20 
min of vigorous-intensity physical activity on at least 3 days every week, or an equivalent combination 
achieving 600 metabolic equivalent (MET)-min per week (Hallal et al., 2012). Two main experimental 
approaches are used to understand the metabolic disorders related to this deleterious behavior (Pierre 
et al., 2016): 1) physical inactivity, induced in humans by the reduction of the daily number of steps 
performed (from 10000 to less than 5000) (Knudsen et al., 2012; Krogh-Madsen et al., 2010; Reynolds 
et al., 2015) and the wheel locked model in rodents (Roberts et al., 2012); 2) immobilization, induced 
by hindlimb unloading in rodents and bed rest in humans. Even if the latter represents an interesting 
approach to explore metabolic changes occurring with dramatic reduction of skeletal muscle activity 
(Bergouignan et al., 2011), it can be considered as too extreme compared to what physically inactive 
people really experience (Pierre et al., 2016; Roberts et al., 2012). In the present study, we thus choose 
the wheel lock model to study physical inactivity in mice. 
The physiological mechanisms responsible for the development of chronic diseases related to physical 
inactivity has been deeply explored during the last decade (Booth et al., 2017; Gratas-Delamarche et 
al., 2014; Pedersen 2009; Pierre et al., 2016). Among the proposed mechanisms, insulin resistance 
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associated to chronic hyperinsulinemia is considered as a key triggering event promoting lipid storage 
and obesity (Softic et al., 2012; Stumvoll et al., 2000), but also tumor growth and cancer (Tsujimoto et 
al., 2017). Insulin resistance is clinically defined as the inability of a known quantity of exogenous or 
endogenous insulin to increase glucose uptake and utilization. In humans, several studies reported that 
a sudden reduction of physical activity causes whole-body insulin resistance after only few days 
(Knudsen et al., 2012; Krogh-Madsen et al., 2010; Reynolds et al., 2015). In this context, the drastic 
reduction of energy expenditure rapidly occurring in skeletal muscle is currently considered as the 
primary event promoting insulin resistance (Booth et al., 2017). The related gain of fat mass and the 
chronic low grade inflammatory state observed in inactive people are generally proposed as 
responsible for insulin resistance development (Booth et al., 2017; Pedersen 2009). However, insulin 
resistance occurs after few days of physical inactivity whereas systemic inflammatory markers (e.g. 
TNF-α, IL-6) or visceral fat mass generally increase after several weeks in both humans and rodent 
experiments (Hamburg et al., 2007; Krogh-Madsen et al., 2010; Olsen et al., 2008; Rector et al., 
2008). Thus, adipose tissue and inflammation processes do not appear to be the culprits of early 
insulin resistance. 
Physical inactivity, whatever the experimental model, induces a shift in fuel metabolism in favor of 
carbohydrate oxidation and in detriment of lipid oxidation, resulting in an accumulation of 
intramuscular lipids (Bergouignan et al., 2006; Laye et al., 2009; Momken et al., 2011). Lipid 
accumulation in skeletal muscle is well known to be related with insulin resistance, especially due to 
their conversion into ceramides (Samuel and Shulman, 2012). Ceramides are bioactive mediators 
involved in cell responses to stress, and their increase in skeletal muscle is known to induce insulin 
resistance through the inhibitory phosphorylation of proteins of the insulin pathway including insulin 
receptor substrate-1/2 (IRS1/2) and phosphatidylinositol-3-kinase, (PI3-kinase) (Chavez and 
Summers, 2003). Ceramides are synthesized through both stimulation of sphingomyelinase-mediated 
hydrolysis of membrane sphingomyelin, and de novo synthesis pathway consisting of the condensation 
of palmitoyl-CoA with serine (Hannun and Luberto, 2000). Whereas accumulation of intramuscular 
ceramides has been extensively explored in the context of obesity (Schmitz-Peiffer, 2010; Ussher et 
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al., 2010), their role in the onset of insulin resistance related to physical inactivity remains poorly 
understood. 
We hypothesized that physical inactivity rapidly increases ceramide synthesis in skeletal muscle, 
which in turn would induce insulin resistance. Therefore, the present study was designed to analyze, in 
mice, whether inhibition of ceramide synthesis prevents insulin resistance observed after a short period 
of physical inactivity. For this purpose, we used: 1) the wheel lock model to study the effect of 
physical inactivity; 2) myriocin, an inhibitor of de novo synthesis of ceramides (Salaun et al., 2016).
MATERIAL AND METHODS
All procedures described below were approved by the French Ministry of Higher Education and 
Research in accordance with the local committee on Ethics in Research of Rennes (veterinary service 
of health and animal protection, authorization 01259.03). 
Animal care and protocol. To mimic the effects of physical inactivity in mice, we used the wheel lock 
model first developed by Frank Booth’s research group (Roberts et al., 2012). Twenty-two male 
C57BL/6J mice were obtained at weaning (3 weeks) and allowed to acclimatize for 1 week. The 
animals were housed in temperature controlled room (21 ± 2°C) with a 12-h:12-h light/dark cycle and 
received standard rodent chow and water ad libitum. After 1 week, mice were separated into individual 
cages all equipped with a voluntary running wheel outfitted with a lap counter (IntelliBio, Nancy, 
France). Food intake and covered distance were daily noticed whereas body weight was recorded 
every week. The distance daily covered increased the first two weeks and remained unchanged during 
the next 4 weeks. At the end of this period, mice were assigned to 3 experimental groups with equal 
mean and standard deviation for daily covered distance: voluntary wheel access group (Active, n=7), a 
wheel lock group (Inactive, n=7) and wheel lock group treated with myriocin (Inactive-Myr, n=8). 
Myriocin was daily injected (0.3 mg/kg, i.p) as previously described (Hojjati et al., 2005; Lee et al., 
2010). In the same schedule, Active and Inactive groups received saline vehicle. After 10 days of 
physical inactivity, mice were sacrificed in an overnight fasting state. Mice were anesthetized with a 
ketamine-xylazine-butorphanol cocktail. Adipose tissue, rectus femoris (RF) and right tibialis anterior 
Page 5 of 26
. 
6
(TA) muscles were removed, and then immediately frozen in liquid nitrogen. Left tibialis anterior 
muscles were removed, and then submitted to an ex vivo insulin sensitivity test. Immediately following 
tissue harvest, mice were euthanized via exsanguination of the heart. Intracardiac blood was collected 
into dry tubes and centrifuged (1,500 g, 10 min) for serum sampling. 
Glucose tolerance assessment. Oral glucose tolerance test (OGTT) was performed on the morning one 
day before sacrifice. Mice were fasted for 6h before the test. Then, glucose was administrated by oral 
gavage (1 g/kg body weight). Glucose values were obtained at rest and 15, 30, 45, 60, 90, 120 min 
after glucose gavage from tail blood samples. Glucose level was determined using a glucose meter 
(Freestyle Papillon Vision). Wheels were locked during the whole time of fasting and OGTT.
Ex vivo muscle insulin sensitivity test. As previously described (Tardif et al., 2011), left tibialis 
anterior muscles were longitudinally divided in two strips (20-25 mg) and each strip was pre-
incubated for 30 min in 3 mL of modified Krebs Ringer buffer (120 mM NaCl, 4.8 mM KCl, 25 mM 
NaHCO3, 2.5 mM CaCl2, 1.24 mM NaH2PO4, 1.25 mM MgSO4, 8 mM D-Glucose, 2 mM sodium 
pyruvate, 2 mM HEPES, pH 7.4) saturated with a 95% O2 and 5% CO2 mix at 37°C under stirring. 
One of the two strips was stimulated with 20 nM insulin for 30 minutes, then muscle samples were 
frozen in liquid nitrogen until analysis. Muscle insulin sensitivity was assessed by measuring the 
phosphorylation state of Akt on serine 473, an intermediate of the insulin pathway.
Serum parameters. Glucose concentrations were performed using Automated Beckman Coulter 
(Beckman Coulter, Brea, CA). Serum insulin concentrations were measured by enzyme-linked 
immunosorbent assay (ELISA) according to manufacturer’s instructions (Millipore, St Louis, MO, 
USA). Insulin sensitivity was determined by calculating HOMA-IR according to the following 
formula (Matthews et al., 1985): HOMA-IR = [fasting glucose (mmol/l)] × [fasting insulin (μU/ml)] 
/22.5.
Quantification of muscle triglycerides. Muscle triglycerides were determined by using DiaSys kit 
(Diagnostic System, Grabels, France) following a preliminary organic phase extraction according to 
Bligh & Dyer’s method (Bligh and Dyer, 1959).  Briefly, 30 mg of right tibialis anterior samples were 
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crushed with 300 μL of 150 mM sodium chloride. Then 150 μL of muscle homogenates were 
extracted with 600 μL of a methanol-chloroform mixture (1:1, v/v). The organic layers were collected 
after centrifugation (10,000g for 10 min) and dried under nitrogen. Dry samples were reconstituted in 
37.5 μL of isopropanol/acetonitrile/water mixture (2:1:1, v/v/v) and 10 μL were analyzed according to 
the manufacturer recommendations.
Quantification of muscle sphingolipids and ceramides. Sphingolipids were extracted from ≈ 30 mg of 
homogenized tibialis anterior muscles using acidified cyclohexane/isopropanol mixture (60:40, v/v, 
0.1% formic acid) and purified on NH2 SPE cartridges (silica gel cartridges, 100 mg) to obtain distinct 
fractions of ceramides and sphingomyelins (Bodennec et al., 2000). The sphingolipid fractions were 
then quantified by UHPLC-ESI-MS/MS using an Acquity H-Class UHPLC system (Waters, Milford, 
MA) combined with a Waters Xevo TQD triple quadrupole mass spectrometer. Lipid extracts were 
injected onto a C18 BEH column (2.1 mm x 50.0 mm, 1.7-µm particles; Waters) held to 43°C to 
separate all species of ceramides and sphingomyelins with two different LC elution gradients. For 
ceramide species separation, the gradient started at 95% of eluent B (mobile phase of water and of 
methanol with 1% formic acid and 5 mM ammonium formate), up to 98% in 4 min, then rapidly 
decreased to 95% for 0.1 min, and was maintained for 2 min. For sphingomyelin species separation, 
the gradient started at 95% of eluent B, up to 99% for 6 min, then rapidly decreased to 95% for 0.1 
min, and was maintained for 1.4 min. Multiple reaction-monitoring mode in positive electrospray 
ionization was used to quantify each species of ceramides and sphingomyelins. The source heater 
temperature hold at 150°C, and the capillary voltage was set at 3.2 kV. The flow rate of desolvation 
gas was of 650 l/h at 350°C, and the cone voltage varied from 26–58 V. Argon was used as the 
collision gas, and collision energies varied from 12–40 eV. Data analyses were performed by Mass 
Lynx software version 4.1 (Waters, Manchester, UK). Sphingolipid quantification was possible with 
calibration curves constructed by plotting the peak area ratios of analyses to the respective internal 
standard against concentration using a linear regression model. The quantification measurements were 
performed using the TargetLinks software (Waters).
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RNA extraction and quantitative real-time PCR. Total RNA extraction from frozen rectus femoris was 
performed with Trizol® (Invitrogen, France) according to the manufacturer’s instructions. The RNA 
quality and quantity were assessed by FlashGel DNA System® and Nanodrop® spectrophotometry, 
respectively. Reverse transcription was performed on a T100 Thermal Cycler (Bio-Rad) with iScriptTM 
cDNA synthesis kit (Bio-Rad) from 1 µg total RNA. Real time PCR experiments were done on a 
CFX96 Real Time System (Bio Rad). Samples were analyzed in duplicate in 10 µl reaction volume 
containing 4.8 µl IQTMSybr®GreenSuperMix (Bio-Rad), 0.1 µl of each primer (100 nM final) and 5 µl 
of diluted cDNA. The following primer sequences were used: GLUT4: (F: 
GCCTGCCCGAAAGAGTCTAA and R: CATTGATGCCTGAGAGCTGTTG); PPIA (F: 
CGTCTCCTTCGAGCTGTTTG and R: CCACCCTGGCACATGAATC); HPRT (F: 
AGGCCAGACTTTGTTGGATTT and R: CAGGACTCCTCGTATTTGCAG); RPL19 (F: 
CAATGCCAACTCTCGTCAACAG and R: CATCCAGGTCACCTTCTCGG). GLUT4 was 
normalized using three reference genes (PPPIA, HPRT, RPL19) according to geNorm analysis 
(Vandesompele et al., 2002).
Western Blotting. Cytosolic protein extraction was performed from rectus femoris muscle in cold lysis 
buffer containing 10 mM Tris-HCl, pH 7.4, 0.5 M sucrose, 50 mM NaCl, 5 mM EDTA, 30 mM 
Na4P2O7, 1% NP-40, 0.25% sodium deoxycholate, 50 mM NaF, 100 µM sodium orthovanadate and 
proteases inhibitors cocktail (Sigma P8340, 5 µl/ml). The samples were homogenized using a Polytron 
homogenizer at 4°C. Each sample was then incubated on ice for 30 min followed by 3 x 10 s of 
sonication. The homogenates were then centrifugated at 12,000g for 12 min at 4°C. The protein 
concentration of the supernatant was determined by a Lowry assay using bovine serum albumin (BSA) 
as standard. Samples were then diluted in SDS-PAGE sample buffer [50 mM Tris-HCl, pH 6.8, 2% 
SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.1% bromophenol blue], and heated 5 min at 95°C 
until analyses. Fifty micrograms of proteins were resolved on 12.5% SDS-PAGE. The proteins were 
transferred at 240 mA for 90 min onto a 0.2-µm nitrocellulose membrane. Membranes were blocked 
with 5% BSA or nonfat dry milk in TBST (Tris-buffered saline - 0.05% Tween-20) for 1 h at room 
temperature. Membranes were incubated overnight at 4°C with appropriate primary antibodies: AKT 
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(1:1000, Cell Signaling), p-AKTSer473 (1:1000, Cell Signaling),  AMPK (1:1000, Cell Signaling), p-
AMPKThr172 (1:1000, Cell Signaling), p65 (1:1000, Cell Signaling), p-p65Ser536 (1:1000, Cell 
Signaling), IRS-1 (1:1000, Cell Signaling), pIRS-1Ser302 (1:1000, Cell Signaling), STAT3 (1:1000, Cell 
Signaling), p-STAT3Ser727, IκBα (1:1000, Cell Signaling), GLUT4 (1:1000, Abcam), and α-actin 
(1:700, Sigma Aldrich). Thereafter, membranes were washed with TBST and incubated for 1 h at 
room temperature with infrared dye-conjugated secondary antibodies (LI-COR, Lincoln, NE, USA). 
After washing, blots were captured using the Odyssey Imaging System (LI-COR). All blots were 
scanned, densitometric analysis of the bands was conducted using GS-800 Imaging densitometer and 
QuantityOne software. Phosphospecific signal was normalized to the total signal to estimate the ratio 
of activated markers.
Statistical analysis. Data are presented as mean ± SEM. Normality and equality of variances were 
checked using a Kolmogorov-Smirnov and Fischer test, respectively. A one-way analysis of variance 
(ANOVA) was performed to compare each parameter between the 3 experimental groups. When 
appropriate, the Fisher LSD test was used as a post-hoc analysis. If normality and/or equal variance 
tests failed, we checked the significance using one-way ANOVA on ranks (Kruskal-Wallis). When 
appropriate, the Dunn’s test was used as a post-hoc analysis. For all statistical analyses, the 
significance level was set at 0.05. Data were analyzed using the statistical package GraphPad Prism 
version 6.02 for Windows (GraphPad Software, La Jolla, California).
RESULTS
Physical activity levels, body weight, food intake and visceral fat mass. During the 10 days of wheel 
lock, Active mice exhibited a mean daily physical activity levels of 3.90 ± 0.78 km/day. Daily food 
intake was lower in both Inactive and Inactive-Myr mice compared to Active mice (-7.9% and -7.6%, 
p=0.007 and 0.01, respectively, Table 1). After 10 days of wheel lock, body weight significantly 
increased only in Active mice. No significant difference of body weight was observed between the 3 
Page 9 of 26
. 
10
experimental groups before and after the 10 days of physical inactivity. Visceral fat mass did not differ 
between the 3 experimental groups at the end of the protocol (Table 1). 
Muscle triglycerides, ceramides and sphingomyelin content. We first observed that muscle triglyceride 
(TG) content tends to increase in Inactive mice (p=0.09, Fig. 1A) whereas it increases in the Inactive-
Myr group (p=0.027, Fig. 1A). Contrary to our hypothesis, physical inactivity did not modify total, 
saturated and unsaturated ceramides content in muscle (Fig. 1B). Individual ceramides species ranging 
from C16:0 to C24:1 remained also unchanged after 10 days of physical inactivity (Fig. 1C and 1D). 
Surprisingly, muscle ceramides content was not affected by 10 days of myriocin treatment (Fig. 1B, 
1C and 1D). Total, saturated and unsaturated sphingomyelin content also remained unchanged with 
physical inactivity and after myriocin treatment (Fig. 1E). 
Whole-body insulin sensitivity and glucose tolerance. The effect physical inactivity and myriocin 
treatment on whole-body insulin sensitivity was assessed by measuring the circulating level of glucose 
and insulin. Fasting glycemia remained unaffected with physical inactivity and myriocin treatment 
(Fig. 2A). Serum insulin levels were higher in both Inactive and Inactive-Myr groups compared to 
Active group (p=0.025 and 0.015, respectively, Fig. 2B). Such results were associated with a higher 
HOMA-IR index in Inactive compared to Active mice (p=0.045, Fig. 2C), whereas this index did not 
differ between Inactive-Myr and Active mice (p=0.17, Fig. 2C). Thus, myriocin seems to prevent 
physical inactivity-induced whole-body insulin resistance. An OGTT was also performed at the end of 
the protocol to observe the effects of physical inactivity and myriocin on glucose tolerance. Here, we 
did not observe significant difference in glucose concentrations (at all time points) and area under the 
curve (AUC) between Active and Inactive mice (Fig. 2D and E). However, we reported that Inactive-
Myr mice exhibited an AUC significantly lower compared to both Active (p=0.019, Fig. 2D) and 
Inactive mice (p<0.001, Fig. 2D). This effect was due to a lower glucose levels both at the beginning 
and the end of OGTT (15 min, 30 min, 90 and 120 min, p<0.05, Fig. 2E). Taken together, our results 
indicate that myriocin improves glucose tolerance.
Proximal insulin signaling and GLUT4 content in skeletal muscle. We observed a deleterious effect of 
physical inactivity on whole-body insulin sensitivity and a beneficial effect of myriocin on glucose 
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tolerance. To investigate the mechanism regulating such effects, we first evaluated the integrity of 
insulin signaling in skeletal muscle by measuring, ex vivo, basal and insulin-stimulated Akt activation. 
We observed that insulin stimulation increased phospho-Akt levels in Active (p=0.019), Inactive 
(p=0.029) and Inactive-Myr (p<0.001, Fig. 3A). Whereas the magnitude of these responses did not 
differ between Active and Inactive mice, Inactive-Myr mice exhibited a higher muscle activation of 
Akt in response to insulin when compared to both Active and Inactive mice (p=0.046 and p=0.036, 
respectively, Fig. 3A). Glucose uptake is recognized to be regulated by insulin signaling and GLUT4 
pool in skeletal muscle (Pierre et al., 2016). In the present study, we observed that physical inactivity 
reduced GLUT4 protein (p=0.043, Fig. 3B and 3E), but not GLUT4 mRNA (Fig. 3C). Interestingly, 
we observed that myriocin treatment prevent the reduction of muscle GLUT4 protein induced by 
physical inactivity (p=0.005, Fig. 3B). At the mRNA level, GLUT4 was reduced by myriocin in 
Inactive-Myr compared to Inactive mice (p=0.031, Fig. 3B). As AMP-activated protein kinase 
(AMPK) is recognized to regulate GLUT4 expression and it translocation to the membrane (McGee et 
al., 2008), we decided to measure the levels of AMPK activation in skeletal muscle. We reported that 
AMPK activation remained unchanged in Inactive compared to Active mice (Fig. 3D and E). 
Interestingly, we showed that AMPK activation was higher in myriocin-treated mice compared to both 
Active and Inactive mice (p=0.031 and p=0.003, respectively, Fig. 3D and 3E). In insulin-resistant 
rodent models, chronic hyperphosphorylation of IRS1 on Ser302 has been identified as playing a key 
role in muscle insulin resistance (Morino et al., 2008). In our experiments, no significant change was 
observed in the phosphorylation state of IRS1 on Ser302 between the 3 experimental groups (Fig. 4A 
and 4E). Muscle insulin resistance is also related to activation of  NF-ΚB and IL6/STAT3 
inflammatory signaling pathways (Gratas-Delamarche et al., 2014). Here, we reported that physical 
inactivity combined or not with myriocin treatment did not modulate phospho-p65 and IKBα (Fig. 4C 
and 4E), two well-recognized markers of NF-KB activation (Christian et al., 2016). Similarly, 
phosphorylation of STAT3 on Ser727  remained unchanged in the three experimental groups (Fig. 4B 
and 4E). 
DISCUSSION
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Muscle ceramides are known to play a key role in the development of insulin resistance during high 
fat nutritional intake, but their role in physical inactivity-induced insulin resistance are poorly 
understood. Our data support that early insulin resistance observed with physical inactivity is not due 
to ceramide accumulation and disrupted insulin signaling in skeletal muscle, but could be caused by a 
reduction in muscle GLUT4 content. We also observed that 10 days of myriocin treatment in inactive 
mice improve glucose tolerance, but surprisingly through a mechanism that appears independent of 
changes in muscle ceramide content. 
Immobilization rapidly causes both in humans and rodents a reduction in fatty acid (FA) transport to 
mitochondria and in mitochondrial FA β-oxidation, resulting in an accumulation of intramuscular 
lipids (Bergouignan et al., 2006; Kwon et al., 2016; Laye et al., 2009; Momken et al., 2011; Salaun et 
al., 2016). Saturated FA oxidation, including palmitate, are particularly reduced in skeletal muscle 
during immobilization (Bergouignan et al., 2011). Interestingly, palmitate is well identified to increase 
the expression of serine palmitoyltransferase 2 (SPT2), a key enzyme in ceramide biosynthesis 
(Erickson et al., 2012). Ceramides have been identified as key bioactive sphingolipids in the 
development of muscle insulin resistance, especially the C:16 and C:18 moieties, which are the most 
abundant in skeletal muscle (Chung et al., 2017; Perreault et al., 2018). Based on previous data from 
our laboratory and others showing in rodents that C:16 and C:18 ceramides increase in skeletal muscle 
after 1 or 2 weeks of immobilization (Kwon et al., 2016; Salaun et al., 2016), we hypothesized that 10 
days of physical inactivity induced by wheel lock will also cause muscle ceramide accumulation. 
Contrary to immobilization, we observed that total and saturated ceramide levels in muscle remained 
unchanged after 10 days of physical inactivity. This was also the case for muscle TG which are 
increase after immobilization (Kwon et al., 2016; Salaun et al., 2016), while we reported only a trend 
with physical inactivity. In those studies, ceramides content has been measured in rodent soleus 
muscle that mainly contain type 1 fibers. As in the present study ceramides content has been measured 
in tibialis anterior that contain type 2 fibers, it could partly explain why immobilization and physical 
inactivity induce a distinct effect on muscle ceramides content. Alternatively, immobilization is a 
more drastic model than physical inactivity, this could also explain why muscle ceramides content 
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increase in one case but not the other, and this independently of muscle fiber type (Salaun et al., 2016). 
Despite these limitations, the present study supports that muscle ceramides are not responsible of 
insulin resistance induced by physical inactivity. Nevertheless we cannot exclude that other lipid 
intermediates (e.g diacylglycerol and long chain acyl-CoA) could play a role in physical inactivity-
induced muscle insulin resistance.   
In rodents, the wheel lock model is currently the closest model to mimic human physical inactivity 
(Roberts et al., 2012). Using this model in mice, we observed that 10 days of physical inactivity are 
sufficient to induce hyperinsulinemia and to increase the HOMA-IR, both considered as hallmarks of 
insulin resistance (Singh and Saxena, 2010). These results are in accordance with previous studies 
conducted in Sprague-Dawley or OLETF rats after 7 days of wheel lock (Rector et al., 2010, 2008; 
Teich et al., 2017). Few data are available about the effects of the wheel lock model on glucose 
tolerance. Teich and colleagues recently observed that 7 days of wheel lock were sufficient to affect 
glucose tolerance in young Sprague-Dawley male rats (Teich et al., 2017). In the present study, we did 
not report an effect on glucose tolerance after 10 days of wheel lock. Our results are in accordance 
with data obtained in humans exposed to a reduction in daily number of steps during 5 or 14 days, 
where no change in glucose tolerance was reported (Knudsen et al., 2012; Reynolds et al., 2015). All 
together, these results sustain that the wheel lock model is a realistic experimental set-up to study, in 
mice, human physical inactivity and its role in chronic diseases development.
Skeletal muscle being responsible of 80% of whole-body glucose uptake under insulin stimulation 
(DeFronzo et al., 1985), early insulin resistance occurring with physical inactivity is mainly attributed 
to alterations in skeletal muscle glucose uptake (Knudsen et al., 2012; Krogh-Madsen et al., 2010). 
Interestingly, using the wheel lock model during only 2 days, Kump and Booth observed a reduction 
of insulin-stimulated 2-deoxyglucose uptake in skeletal muscle (Kump and Booth, 2005). Similar 
results were also reported in rats submitted to muscle unloading after 24h (Kawamoto et al., 2016; 
O’keefe et al., 2004). However, the mechanisms by which physical inactivity and muscle unloading 
rapidly induce muscle insulin resistance remain unclear. Krogh-Madsen and colleagues (2010) have 
reported that a reduction of muscle Akt phosphorylation during hyperinsulinemic euglycemic clamp 
occurred after 2 weeks of reduction of ambulatory activity, thus supporting the idea that insulin 
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signaling was early affected by physical inactivity. However, if the clamp is the gold standard to 
assess peripheral insulin sensitivity, it appears less appropriate to assess insulin signaling. Indeed, 
presence of circulating hormones or cytokines (e.g. leptin, adiponectin, IL-6) and muscle contractility 
are all factors affecting muscle insulin signaling during clamp, independently of direct action of 
insulin. For these reasons, we decided to explore insulin-stimulated muscle Akt phosphorylation in ex-
vivo conditions to determine whether insulin signaling was affected with a short period of physical 
inactivity. In this condition, we observed that Akt phosphorylation in inactive mice did not differ from 
active animals, suggesting that insulin signaling until Akt remains unaffected after 10 days of physical 
inactivity. To support such results, we explored the effects of physical inactivity on inflammatory 
pathways recognized to affect insulin signaling. Here, neither NF-κB nor IL-6/STAT3 signaling 
pathways were affected in skeletal muscle of inactive mice. Further, in response to pro-inflammatory 
state IRS1 is inhibited by a phosphorylation on its Ser302 (Gratas-Delamarche et al., 2014; Hage 
Hassan et al., 2016; Morino et al., 2008). In the present study, we found that physical inactivity did not 
modify the phosphorylation state IRS1Ser302. Taken together, these results indicate that, in the context 
of physical inactivity, the onset of insulin resistance is not due an inflammatory process affecting the 
skeletal muscle. 
Our data support that muscle insulin signaling does not appear affected by a short period of physical 
inactivity. In accordance with Kump and Booth (2005), we reported that 10 days of wheel lock caused 
a significant reduction of GLUT4 pool in skeletal muscle. These results support the idea that 
inactivity-induced muscle insulin resistance would be rather related to a decrease of muscle GLUT4 
pool than a defect in insulin signaling. Interestingly, we observed that mRNA coding for GLUT4 was 
not affected suggesting that the decrease of GLUT4 pool would be due to an increase of its 
degradation. It is well established that chronic insulin stimulation causes a decrease of GLUT4 content 
in adipocytes, mainly due to an accelerated GLUT4 degradation in the lysosomes (Liu et al., 2007; Ma 
et al., 2014, p. 4; Sargeant and Pâquet, 1993). Similar cellular events could occur in skeletal muscle of 
inactive. Such mechanisms need to be explored in further experiments. 
To explore the role of ceramides in physical inactivity-induced insulin resistance, we treated inactive 
mice with myriocin, an inhibitor of de novo synthesis of ceramides. As previously reported in others 
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experimental models including Zucker diabetic rats or high fat diet-fed mice (Holland et al., 2007; 
Ussher et al., 2010), we observed that myriocin treatment improved glucose tolerance in inactive mice. 
Interestingly, we concomitantly observed in skeletal muscle that myriocin improves muscle insulin 
signaling and AMK activation, and prevents the decrease of GLUT4 pool induced by physical 
inactivity. This result is in accordance with the data of Liu and colleagues (2013) demonstrating that 
myriocin prolonged yeast lifespan by activating key signaling pathways controlling stress resistance 
and energy metabolic homeostasis including AMPK signaling pathway. Thus, our results support that 
the beneficial effect of myriocin on glucose tolerance may be mediated by an improvement of both 
insulin- and AMPK-dependent muscle glucose uptake (Jensen et al., 2014). Contrary to our 
hypothesis, the benefits of myriocin treatment on glucose tolerance are not associated to modulation in 
muscle ceramide concentrations. The previous studies reporting in mice a beneficial effect of myriocin 
on glucose tolerance and insulin sensitivity were systematically associated to a prevention of muscle 
ceramide accumulation induced by high fat diet or pathological genetic background (Holland et al., 
2007; Ussher et al., 2010; Yang et al., 2009). Herein, we found that myriocin could also act on insulin 
sensitivity independently from ceramides, thus highlighting the need to explore new mechanisms 
linking myriocin and insulin sensitivity. 
In summary, our results support that muscle ceramide accumulation and inflammatory pathways do 
not play a role in physical inactivity-induced insulin resistance. Our data support that insulin resistance 
observed after a short period of physical inactivity appears related to a reduction in muscle GLUT4 
content rather than to defects of muscle insulin signaling. 
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Table 1. Effects of physical inactivity and myriocin treatment on body weight, food intake and 
visceral fat mass.
Active Inactive Inactive-Myr
Body weight (g)
Before locking 25.2 ± 0.5 25.8± 0.2 24.8 ± 0.2
10 days post-locking 25.8 ± 0.6$ 25.9 ± 0.2 24.5 ± 0.3
Food intake (g/day) 4.16 ± 0.05 3.83 ± 0.09* 3.84 ± 0.08*
Physical activity (km/day) 3.90 ± 0.78 ------------ --------------
Visceral fat mass (g/100 g BW) 2.12 ± 0.19 2.30 ± 0.25 2.08 ± 0.15
Data are presented as mean ± SEM (n=7-8/group).  Significant differences (p< 0.05) are indicated as 
follows: comparison vs. values before wheel locking ($), comparison vs. Active group (*)
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Figure 1. Effects of physical inactivity and myriocin treatment on lipids profile. Data are 
presented as mean ± SEM (n=7-8/group). A: triglycerides content. B: total, saturated, and unsaturated 
ceramide content. C: unsaturated species profile. D: saturated species profile. E: total, saturated, and 
unsaturated sphingomyelin content. Significant differences are indicated as follows: comparison vs. 
Active group (*: p<0.05)
Figure 2. Effects of physical inactivity and myriocin treatment on whole-body insulin sensitivity 
and glucose tolerance.  Data are presented as mean ± SEM (n=7-8/group). A: serum glucose 
concentrations. B: serum insulin concentrations. C: HOMA-IR index. D: area under the curve (AUC) 
for OGTT. E: evolution of glycemia following oral glucose load. Significant differences are indicated 
as follows: comparison vs. Active group (*: p<0.05), comparison vs. Inactive group (###: p<0.001)
Figure 3. Effects of physical inactivity and myriocin treatment on muscle insulin signaling. Data 
are presented as mean ± SEM (n=7-8/group). A: Insulin-stimulated Akt activation in skeletal muscle of 
different experimental groups. B: muscle GLUT4 protein content muscle. C: GLUT4 mRNA levels. D: 
muscle AMPK activation.  E: representative Western Blot of the data obtained in panel C and D. 
Significant differences are indicated as follows: comparison vs. Active group (*: p<0.05), comparison 
vs. Inactive group (#: p<0.05, ##: p<0.01)
Figure 4. Effects of physical inactivity and myriocin treatment on signaling pathways involved in 
muscle insulin resistance. Data are presented as mean ± SEM (n=7-8/group).  A: IRS1Ser302 activation. 
B: STAT3 activation.  C: IκBα content. D: NF-κB p65 activation. E: representative Western Blot 
analyses of proteins involved in muscle insulin resistance.
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